OCUL - long - upcoming catalyst

27 ene

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

This is not a financial advice!

Recent block buy

Upcoming catalyst

Keep an eye on 5.0 level - needs to get broken for a further upmove.

SL under 3.7

TP approx. 9.0 maybe even to 12.00 area.

Most info on the chart.

Trade carefully!

9 feb

Nota

luv it

16 feb

Nota

yesss babyy, feel free to take gains if u want.

20 feb

Operación cerrada: objetivo alcanzado

1 mar

Nota

omg what a trade

14 jun

Nota

20 jun

Nota

Boom hit 6.45 today!

Ocular Therapeutics shares are trading higher after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $7 to $11.

the smell is with you!

26 jun

Nota

Wednesday June 26, 2024
01:38:49PM
OCUL
Block Trade: OCUL 998,082 @ $6.60 above ask of 6.52